Aug 28, 2026 06:40PM
Aug 28, 2026 06:40PM
Aug 24, 2026 02:36AM
Aug 5, 2026 06:10PM
Aug 5, 2026 06:10PM
Jul 30, 2026 02:37AM
Jul 16, 2026 06:00PM Takeda psoriasis drug shows skin clearance in Phase 3 trials
Jul 16, 2026 06:00PM
Jul 12, 2026 07:00PM
Jun 24, 2026 03:05AM
Jun 15, 2026 12:00PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Jun 9, 2026 04:30PM U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
May 13, 2026 02:38AM
May 4, 2026 08:00AM
May 4, 2026 08:00AM
Mar 28, 2026 03:00PM
Mar 2, 2026 02:00AM
Feb 19, 2026 12:00PM
Feb 19, 2026 12:00PM Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
Feb 10, 2026 03:15AM
Jan 29, 2026 01:37AM
Jan 22, 2026 07:45AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:00AM
Dec 18, 2025 03:00AM
Dec 18, 2025 03:00AM Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
Dec 6, 2025 09:30AM
Nov 7, 2025 11:00AM
Nov 3, 2025 08:33AM
Nov 3, 2025 07:00AM
Oct 30, 2025 03:04AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM Takeda partners with Innovent for $1.2 billion oncology deal
Oct 21, 2025 08:25PM
Sep 23, 2025 06:04PM
Sep 16, 2025 08:00AM
Sep 11, 2025 08:45AM
Sep 11, 2025 08:45AM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:00AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 03:07AM Takeda Announces New Assignments of Directors
Jun 3, 2025 10:13AM

1,185,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All